Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bgb-324
2. Bgb324
3. R-428 Compound
4. R428 Compound
1. 1037624-75-1
2. R428
3. Bgb324
4. Bgb-324
5. R-428
6. Bemcentinib [usan]
7. 0icw2lx8as
8. Cs-1046
9. Hy-15150
10. Qc-11751
11. Chembl3809489
12. W-5845
13. Syn-1131
14. (s)-1-(6,7-dihydro-5h-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-n3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5h-benzo[7]annulen-2-yl)-1h-1,2,4-triazole-3,5-diamine
15. Kb-80319
16. 1h-1,2,4-triazole-3,5-diamine, 1-(6,7-dihydro-5h-benzo(6,7)cyclohepta(1,2-c)pyridazin-3-yl)-n3-((7s)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5h-benzocyclohepten-2-yl)-
17. Unii-0icw2lx8as
18. Syn1131
19. R 428
20. R428 (bgb324)
21. Bemcentinib (r428)
22. Bemcentinib Intermediate
23. Bemcentinib [inn]
24. Bemcentinib (usan/inn)
25. Bemcentinibr428bgb324)
26. Bemcentinib [who-dd]
27. Schembl1639904
28. Gtpl10478
29. Bgb 324
30. Dtxsid70673109
31. Amy16774
32. Bcp21180
33. Ex-a1720
34. Bdbm50172079
35. Nsc824183
36. S2841
37. Who 10631
38. Zinc51951669
39. Akos032947237
40. Db12411
41. Nsc-824183
42. Ncgc00386665-07
43. Ac-28444
44. As-16270
45. D11438
46. A856079
47. Q27236818
48. Bgb324; Bgb-324; Bgb 324; R 428; R-428; Bemcentinib
49. 1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-n-[(7s)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
50. 1-(6,7-dihydro-5h-benzo(6,7)cyclohepta(1,2-c)pyridazin-3-yl)-n3-((7s)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5h-benzo(7)annulen-2-yl)-1h-1,2,4-triazole-3,5-diamine
51. 1-(6,7-dihydro-5h-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-n3-(7-(s)-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5h-benzo[7]annulene-2-yl)-1h-1,2,4-triazole-3,5-diamine
52. 1-(6,7-dihydro-5h-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-n3-[(7s)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5h-benzocyclohepten-2-yl]-1h-1,2,4-triazole-3,5-diamine;bgb324 ; Bgb-324 ; Bgb 324;r428 (bgb324; Bemcentinib)
| Molecular Weight | 506.6 g/mol |
|---|---|
| Molecular Formula | C30H34N8 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 506.29064312 g/mol |
| Monoisotopic Mass | 506.29064312 g/mol |
| Topological Polar Surface Area | 97.8 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 775 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bemcentinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bemcentinib, including repackagers and relabelers. The FDA regulates Bemcentinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bemcentinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bemcentinib supplier is an individual or a company that provides Bemcentinib active pharmaceutical ingredient (API) or Bemcentinib finished formulations upon request. The Bemcentinib suppliers may include Bemcentinib API manufacturers, exporters, distributors and traders.
Bemcentinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bemcentinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bemcentinib GMP manufacturer or Bemcentinib GMP API supplier for your needs.
A Bemcentinib CoA (Certificate of Analysis) is a formal document that attests to Bemcentinib's compliance with Bemcentinib specifications and serves as a tool for batch-level quality control.
Bemcentinib CoA mostly includes findings from lab analyses of a specific batch. For each Bemcentinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bemcentinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Bemcentinib EP), Bemcentinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bemcentinib USP).
LOOKING FOR A SUPPLIER?
